(Q35218765)

7 August 2017

1 reference

title

Treating the full spectrum of dementia with memantine (English)

1 reference

7 August 2017

1 reference

1

Bengt Winblad

1 reference

7 August 2017

Vesna Jelic

2

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

International Journal of Geriatric Psychiatry

7 August 2017

published in

1 reference

7 August 2017

volume

18

1 reference

7 August 2017

issue

Suppl 1

1 reference

7 August 2017

page(s)

S41-6

1 reference

Prognostic factors in very old demented adults: a seven-year follow-up from a population-based survey in Stockholm

7 August 2017

cites work

1 reference

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation

21 January 2018

1 reference

7 January 2021

Stability of the preclinical episodic memory deficit in Alzheimer's disease.

1 reference

7 January 2021

Neuroprotective and symptomatological action of memantine relevant for Alzheimer's disease--a unified glutamatergic hypothesis on the mechanism of action.

1 reference

7 January 2021

The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

1 reference

7 January 2021

Behavioural activities in demented geriatric patients. Study based on evaluations made by nursing staff members and on patients' scores on a simple psychometric test

1 reference

7 January 2021

1 reference

7 January 2021

Do cholinesterase inhibitors have disease-modifying effects in Alzheimer's disease?

1 reference

7 January 2021

Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain.

1 reference

7 January 2021

Costs of Mini Mental State Examination-related cognitive impairment.

1 reference

7 January 2021

beta-amyloid protein enhances macrophage production of oxygen free radicals and glutamate

1 reference

7 January 2021

Diagnostic accuracy of Alzheimer's disease: a neuropathological study.

1 reference

7 January 2021

Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium

1 reference

7 January 2021

New approaches to clinical trials in vascular dementia: memantine in small vessel disease

1 reference

7 January 2021

Mild cognitive impairment: clinical characterization and outcome

1 reference

7 January 2021

Memantine in moderate-to-severe Alzheimer's disease

1 reference

7 January 2021

Lessons from mixed dementia

1 reference

7 January 2021

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

7 January 2021

Rapid appearance of beta-amyloid precursor protein immunoreactivity in glial cells following excitotoxic brain injury

1 reference

7 January 2021

Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians

1 reference

7 January 2021

A follow-up study of the family with the Swedish APP 670/671 Alzheimer's disease mutation.

1 reference

7 January 2021

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

1 reference

7 January 2021

Cost of illness due to dementia in Sweden

1 reference

7 January 2021

Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine).

1 reference

7 January 2021

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.937

1 reference

7 August 2017

1 reference